ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SteadyMed Ltd.
4.73
0.0000
成交量：
- -
成交額：
- -
市值：
1.26億
市盈率：
-10.22
高：
4.73
開：
4.73
低：
4.73
收：
4.73
52周最高：
6.35
52周最低：
2.60
股本：
2,674.28萬
流通股本：
563.00萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.4623
每股收益(LYR):
-0.9502
淨資產收益率：
--
總資產收益率：
--
市淨率：
29.26
市盈率(LYR):
-4.97
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
SteadyMed Ltd.
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.steadymed.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
SteadyMed Ltd.在以色列註冊成立，於2005年6月15日開始其業務，該公司是一家專業製藥公司，專註於治療候選產品的開發和商業化，以解決市場領先的產品在某些孤兒和其他定義良好的，高利潤的專業市場的局限。它們的主要精力是獲得批准銷售Trevyent的肺動脈高壓，或PAH治療。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/STDY/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"STDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STDY\",,,,,undefined,":{"symbol":"STDY","market":"US","secType":"STK","nameCN":"SteadyMed Ltd.","latestPrice":4.725,"timestamp":1557518400000,"preClose":4.725,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":5630000,"shares":26742788,"eps":-0.462262,"marketStatus":"停牌","change":0,"latestTime":"05-10 16:00:00 EDT","open":4.725,"high":4.725,"low":4.725,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.462262,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1426824000000,"exchange":"NASDAQ","adjPreClose":4.725,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STDY\",,,,,undefined,":{"symbol":"STDY","floatShares":5630000,"roa":"--","roe":"--","lyrEps":-0.950195,"shares":26742788,"dividePrice":0,"high":4.725,"amplitude":0,"preClose":4.725,"low":4.725,"week52Low":2.6,"pbRate":"29.26","week52High":6.35,"institutionHeld":0,"latestPrice":4.725,"eps":-0.462262,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.462262,"open":4.725,"prevYearClose":4.725},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STDY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-08-14","symbol":"STDY","fiscalQuarterEnding":"2018/06","expectedEps":-0.19,"name":null,"time":"","type":"earning","dateTimestamp":1534219200000,"reportTimeType":"","actualEps":-0.38},{"market":"US","date":"2018-05-15","symbol":"STDY","fiscalQuarterEnding":"2018/03","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1526356800000,"reportTimeType":"","actualEps":-0.39},{"market":"US","date":"2018-03-30","symbol":"STDY","fiscalQuarterEnding":"2017/12","expectedEps":-0.47,"name":null,"time":"","type":"earning","dateTimestamp":1522382400000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2017-11-13","symbol":"STDY","fiscalQuarterEnding":"2017/09","expectedEps":-0.46,"name":null,"time":"","type":"earning","dateTimestamp":1510549200000,"reportTimeType":"","actualEps":-0.02},{"market":"US","date":"2017-08-11","symbol":"STDY","fiscalQuarterEnding":"2017/06","expectedEps":-0.4,"name":null,"time":"","type":"earning","dateTimestamp":1502424000000,"reportTimeType":"","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STDY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STDY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.steadymed.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"SteadyMed Ltd.在以色列註冊成立，於2005年6月15日開始其業務，該公司是一家專業製藥公司，專註於治療候選產品的開發和商業化，以解決市場領先的產品在某些孤兒和其他定義良好的，高利潤的專業市場的局限。它們的主要精力是獲得批准銷售Trevyent的肺動脈高壓，或PAH治療。","exchange":"NASDAQ","name":"SteadyMed Ltd.","nameEN":"SteadyMed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"STDY\",market:\"US\",,,undefined,":null}}